Particle production rate by controlling beamline pressure
By controlling beamline pressure through periodic gas introduction and evacuation, the method addresses particle contamination in ion implanters, enhancing substrate quality and reducing maintenance interruptions.
Patent Information
- Application Number
- JP2023505458
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-06-18
- Filing Date
- 2021-07-06
- Publication Date
- 2024-11-20
- Estimated Expiration
- 2041-07-06
AI Technical Summary
High-throughput ion implanters face challenges in maintaining low particle contamination levels on substrates during long-term operations, leading to increased defects and the need for frequent cleaning, which disrupts productivity.
Implementing a pressure control routine in the beamline ion implanter by periodically introducing a gas, such as nitrogen, to reach a predetermined pressure in the downstream portion of the beamline, followed by evacuation and reestablishment of injection conditions, thereby reducing particle accumulation.
Significantly reduces particle defects on substrates by maintaining controlled beamline pressure, allowing for continuous high-throughput operations with reduced downtime for cleaning and maintenance.
Smart Images

Figure 0007587677000001 
Figure 0007587677000002 
Figure 0007587677000003
Abstract
Description
[Technical field]
[0001] Related Applications This application claims priority to U.S. Provisional Application No. 63 / 057,640, entitled “IMPROVING PARTICLE YIELD VIA BEAM-LINE PRESSURE CONTROL,” filed July 28, 2020, and incorporated herein by reference in its entirety.
[0002] The present disclosure relates generally to apparatus and techniques for implanting substrates, and more particularly to improved beam-line ion implanter particle yield. [Background technology]
[0003] Ion implantation is the process of introducing dopants or impurities into a substrate by bombardment. In semiconductor manufacturing, dopants are introduced to change electrical, optical, or mechanical properties.
[0004] An ion implantation system may include an ion source and a series of beamline components. The ion source may include a chamber in which ions are generated. The ion source may also include a power supply and an extraction electrode assembly disposed near the chamber. The beamline components may include, for example, a mass analyzer, a first acceleration or deceleration stage, a collimator, and a second acceleration or deceleration stage. Like a series of optical lenses that manipulate a light beam, the beamline components can filter, focus, and manipulate ions or ion beams having a particular species, shape, energy, and / or other quality. The ion beam may pass through the beamline components and be directed toward a substrate attached to a platen or clamp. The substrate may be moved (e.g., translated, rotated, and tilted) in one or more dimensions by a device sometimes referred to as a roplat.
[0005] In many ion implanters, a downstream electrostatic module can act as an electrostatic lens to control ion beam energy, ion beam shape, and ion beam size. The electrostatic module can accelerate or decelerate the ion beam to a final energy while redirecting the ion beam. By redirecting the ion beam, energetic neutrals can be eliminated, resulting in a final beam with a well-defined energy.
[0006] Known electrostatic modules may employ multiple electrode pairs, such as, for example, seven upper and lower electrodes arranged in pairs, which bundle and guide the ion beam traveling therethrough. The electrodes may be arranged as rods spaced equidistant from the ion beam. The rod / electrode potentials are set to create an electric field within the electrostatic module to slow, deflect, and focus the ion beam.
[0007] Some beamline implanters are designed for high throughput, i.e., a relatively higher beam current is used to rapidly implant a target dose of ions into a substrate. For productivity purposes, a greater number of substrates may be targeted for implantation during maintenance or other planned downtime. For example, thousands or tens of thousands of substrates may be implanted during a period of planned maintenance.
[0008] One of the primary concerns during operation of a beamline ion implanter, such as a high current implanter, is the ability to maintain operating conditions that produce high device yields on substrates, such as semiconductor wafers, being implanted. One ongoing challenge is the appearance of particle or particulate defects on the substrates after implantation. Periodic or non-periodic cleaning of the beamline may be performed to reduce particle contamination, at the expense of lost productivity due to the required downtime for cleaning.
[0009] It is with respect to these and other concerns that the present disclosure is provided. Summary of the Invention
[0010] In one embodiment, a method of operating a beamline ion implanter is provided. The method may include performing an ion implantation procedure on a first set of substrates in a process chamber of the ion implanter for a first time period. The method may further include performing a first pressure control routine during the second time period by introducing a predetermined gas into at least a downstream portion of the beamline for a second time period to reach a predetermined pressure. The method may also include performing an ion implantation procedure on a second set of substrates for a third time period after completion of the first pressure control routine.
[0011] In another embodiment, a beamline ion implanter is provided. The ion implanter may include an ion source for generating an ion beam according to an ion implantation procedure. The ion implanter may include a set of components for directing the ion beam along the beamline to a process chamber. The ion implanter may also include a pressure control system including an isolation valve and at least one inlet disposed downstream of the isolation valve for directing a predetermined gas into a downstream portion of the beamline, and a controller configured to instruct the beamline ion implanter to perform a pressure control cycle. The pressure control cycle may include performing an ion implantation procedure on a first plurality of substrates in the process chamber for a first time period, and performing a first pressure control routine during a second time period by introducing the predetermined gas into at least the downstream portion of the beamline for a second time period to reach a predetermined pressure. The pressure control cycle may further include performing an ion implantation procedure on a second plurality of substrates during a third time period after completion of the first pressure control routine. [Brief description of the drawings]
[0012] [Figure 1] FIG. 1 illustrates an exemplary embodiment demonstrating an ion implantation system according to an embodiment of the present disclosure. [Figure 2A]FIG. 1 illustrates defect behavior of implanted wafers as a function of wafer number in dedicated mode. [Figure 2B] FIG. 1 illustrates defect behavior of implanted wafers as a function of wafer number for operation of an ion implanter according to an embodiment of the present disclosure. [Figure 2C] FIG. 2 is a schematic diagram illustrating the principle of application of a pressure control cycle according to an embodiment of the present disclosure. [Figure 2D] FIG. 2 is a schematic diagram illustrating a reference maintenance cycle for an ion implanter. [Diagram 3] FIG. 1 illustrates an exemplary process flow. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0013] The drawings are not necessarily to scale. The drawings are merely representational and are not intended to portray specific parameters of the present disclosure. The drawings are intended to depict exemplary embodiments of the present disclosure and therefore should not be construed as limiting the scope. In the drawings, like numbers represent like elements.
[0014] Systems and methods according to the present disclosure will now be described more fully hereinafter with reference to the accompanying drawings, in which embodiments of the systems and methods are shown. The systems and methods may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the systems and methods to those skilled in the art.
[0015] For purposes of convenience and clarity, terms such as "top," "bottom," "upper," "lower," "vertical," "horizontal," "transverse," and "vertical" shall be used herein to describe the relative placement and orientation of components and their component parts with respect to the geometry and orientation of the components of semiconductor manufacturing devices as they appear in the drawings. The terms shall include the specifically stated words, derivatives thereof, and words of similar import.
[0016] As used herein, elements or operations described in the singular and preceded by the words "a" or "an" are understood to potentially include a plurality of elements or operations as well. Moreover, references to "one embodiment" of the present disclosure are not intended to be interpreted as excluding the existence of additional embodiments that also incorporate the recited features.
[0017] Provided herein are techniques for improved operation and reduced defects in substrates processed in an ion implanter.
[0018] Referring now to FIG. 1, an exemplary embodiment is shown demonstrating a system 10 that may be used as a beamline ion implanter, or "ion implanter," for ion implantation according to the present disclosure. In general, a beamline ion implanter according to the present embodiment will include an ion source and a set of components for directing an ion beam along a beamline to a process chamber. In the example of FIG. 1, the system 10 includes, among other components, an ion source 14 for generating an ion beam 18, such as a ribbon beam or spot beam, and a series of beamline components. The ion source 14 may include a chamber for receiving a flow of gas 24 to generate ions. The ion source 14 may also include a power supply and extraction electrode assembly disposed near the chamber. In some non-limiting embodiments, the beamline components may include, for example, a mass analyzer 34, a mass resolving slit (MRS) chamber 36, and a collimator 38 disposed upstream of an energy filter 40, which may provide deceleration and / or acceleration of the ion beam 18.
[0019] In an exemplary embodiment, components of beamline 16 can filter, focus, and manipulate ions or ion beam 18 to have a certain species, shape, energy, and / or other quality. Ion beam 18 passing through beamline 16 can be directed toward a substrate 15 mounted on a platen or clamp in process chamber 46, or toward an end station. Substrate 15 can be moved (e.g., translated, rotated, and tilted) in one or more dimensions.
[0020] The energy filter 40 is a beamline component configured to independently control the deflection, deceleration, and focus of the ion beam 18. In some embodiments, the energy filter 40 is a vertical electrostatic energy filter (VEEF) or an electrostatic filter EF. The energy filter 40 may be arranged as an electrode assembly defining at least one electrode configuration. The electrode configuration may include multiple electrodes arranged in series along the beamline 16 to process the ion beam 18 passing through the energy filter 40. In some embodiments, the electrostatic filter may include a set of upper electrodes disposed above the ion beam 18 and a set of lower electrodes disposed below the ion beam 18 to direct the ion beam, shape the ion beam 18, and accelerate / decelerate the ion beam 18 before impacting the substrate 15.
[0021] During operation, system 10 may be operated to implant a series of substrates, such as semiconductor wafers. Substrate 15 may be one of a series of substrates that are loaded in a serial fashion for implantation, such as in known ion implanters. In a high throughput mode of operation, system 10 may be operated to implant thousands or tens of thousands of substrates between scheduled downtime intervals.
[0022] The system 10 may include components that address concerns encountered during high throughput operation, specifically the ability to maintain defects in the substrate 15 at or below an acceptable level. As shown in FIG. 1, the system 10 may include an isolation valve 50 located upstream of the process chamber 46, such as between the mass resolving slit (MRS) chamber 36 and the collimator 38. The isolation valve 50 may serve to separate a vacuum region of the downstream portion 16B of the beamline 16 from a vacuum region of the upstream portion 16B of the beamline 16. Although not explicitly shown, the beamline 16 includes a vacuum central enclosure or set of adjacent chambers configured to direct the ion beam 18 from the ion source 14 to the substrate 15 at an operating pressure generally below 1 Torr. The isolation valve 50 may, for example, allow the downstream portion 16B to be vented separately from the upstream portion 16A. In FIG. 1, the isolation valve 50 is located between the mass resolving slit (MRS) chamber 36 and the collimator 38, although in other embodiments the isolation valve 50 may be shifted upstream or downstream from the location shown, or Two or more Isolation valve 50 but , along the beamline. For example, the isolation valve 50 can be placed between the collimator 38 and the energy filter 40, or between the energy filter 40 and the process chamber 46.
[0023] System 10 is also disposed downstream of an isolation valve to direct gas into a downstream portion of beamline 16. Ru1, a collimator inlet 52, an energy filter inlet 54, and a process chamber inlet, or process chamber vent 56, are provided, which may be used to direct gases in and out of locations downstream of the isolation valve 50. The process chamber vent 56 is shown as being located near the front of the substrate 15, but in some embodiments, the process chamber vent, shown as process chamber vent 56', is located toward the backside of the substrate 15, as also depicted in FIG. 1. For example, in a preferred example, when ion implantation is not occurring, a given pressure of bleed gas, such as nitrogen, air, water vapor, reactive gas, or other gas, may be provided through one or more of the inlets or vents. In one example, the energy filter inlet 54 may be located next to the energy filter 40 or next to a plasma flood gun immediately downstream of the chamber of the energy filter 40 (the location of the plasma flood gun is specified by the PFG). In some examples, one or more vents, such as process chamber vent 56, may be coupled to a pump. As such, at a given interval after ion implantation occurs, gas may be bled into downstream portion 16B at one or more locations after isolation valve 50 is engaged to isolate upstream portion 16A.
[0024] In particular, according to an embodiment of the present disclosure, as detailed below, a pressure control routine may be applied to one or more locations of the beamline, such as in the downstream portion 16B. The pressure control routine may involve introducing gas into the beamline to reach a predetermined pressure for a predetermined interval before evacuating the gas from a given portion of the beamline and re-establishing the injection conditions. As noted above, one or more of the isolation valves 50 may be located at different locations along the beamline. In this manner, one or more components of the downstream portion 16B may be isolated from other components of the beamline, so that the target components may be individually subject to a pressure control routine. The advantages of this procedure are described with respect to the figures that follow.
[0025] In some embodiments, the system 10 may include a controller 60 coupled to an inlet, such as through a gas manifold 62, for directing one or more gas species into the downstream portion 16B. The controller 60 may further be coupled to a vent of the downstream portion such that circulation gas into and out of the downstream portion 16B may be controlled as desired. The controller 60 may be configured to direct a pressure control routine as described in more detail below. At least in that regard, the controller 60 may include appropriate hardware components, such as memory, one or more processors, interfaces, etc., for generating, sending, and receiving signals to execute the pressure control routine.
[0026] In some embodiments, an energy discharge source may be provided in downstream portion 16B to generate plasma species, such as ions, metastable species, radical species, or molecular species, which may be used to bombard the interior surface of a target area of downstream portion 16B, including, for example, electrostatic energy filter 40. An example of a discharge source is shown as a remote plasma source 64 positioned adjacent to energy filter 40.
[0027] According to embodiments of the present disclosure, pressure in the beamline 16, such as in the downstream portion 16B, may be controlled in a manner to periodically flow one or more specified gases in and out of a region proximate to the substrate 15, such as the region PFG of the plasma flood gun, or the process chamber 46, or the collimator 38. The inventors have discovered that under certain conditions, particle counts on the substrate may build up to unacceptable levels during long term operation of implantation into the substrate, where control of the beamline pressure in the downstream portion 16B may have a beneficial impact on reducing particle counts.
[0028] To highlight this behavior, FIG. 2A shows the defect behavior of implanted wafers as a function of wafer number during a dedicated implant process. FIG. 2B shows the defect behavior of ion implanted wafers as a function of wafer number for operation of an ion implanter according to an embodiment of the present disclosure. In these examples, a high current implanter is operated to implant a series of substrates in a dedicated mode where the same implant recipe is used to implant all wafers. In FIG. 2A, implantation of the series of wafers proceeds uninterrupted overall for a total of approximately 12,000 wafers, and measurement of defects (adders) is performed at intervals of several hundred to several thousand wafers. Although there is some variation in the defect level, the average defect level generally increases monotonically with increasing wafer number, with a significant percentage of measurements exceeding acceptable limits. Thus, dedicated use of an ion implanter may generate unacceptable levels of defects over time, thus presenting a challenge to high throughput implantation of phosphorus-based wafers.
[0029] Turning now to FIG. 2B, the results of a dedicated ion implant "marathon" are shown where no other implant recipes are used as in FIG. 2A. Unlike the protocol of FIG. 2A, in the example of FIG. 2B, at specific intervals the ion implant is paused and the beamline is pressure controlled with nitrogen gas before pumping down and implantation resumes. The pressure control routine of FIG. 2A involves introducing nitrogen gas into the beamline for an interval before evacuation of the beamline and re-establishment of implant conditions occurs. In some non-limiting examples, nitrogen gas is introduced to reach a pre-defined pressure in the beamline, such as in one or more regions of the downstream portion 16B, and the pressure is increased to several Torr, several hundred Torr, or one atmosphere. This pressure can be maintained for durations ranging from one minute to an hour or so according to different embodiments of the present disclosure. The data in FIG. 2 represents data where the pressure control routine involves passing nitrogen up to a pressure of one atmosphere. Measurements of wafers implanted at different instances are taken similar to the procedure in FIG. 2A, up to a total of about 16,000 wafers. As in the case of FIG. 2A, the defect yield tends to increase with increasing wafer count. For example, between 20,000 and 24,000 wafer counts, the defect yield increases with increasing wafer count, after which a first deliberate pressure control routine is implemented on the beamline using nitrogen at approximately 24,000 wafer count. When implantation resumes at 24,000 wafer count, the particle performance immediately improves by about two orders of magnitude, dropping from about 100 to about 1. The particle count then increases with increasing wafer count, exceeding a value of 100 at approximately 27,000 wafer count. At approximately 28,000 wafer count, a second deliberate pressure control procedure is implemented on the beamline using nitrogen. When implantation resumes at 28,000 wafer count, the particle performance (defects / adders) immediately improves again significantly by about two orders of magnitude, dropping from about 200 to about 1. Again, defect yield increases with increasing wafer count up to a maximum of 35,000 wafers, reaching levels approaching the tolerable limit of 50. However, the overall increase in defects with increasing wafer count is not monotonic; rather, Implementing pressure control routinesWhen this occurs, it is immediately reset to a much lower value.
[0030] According to these results, control of the beamline pressure of the high current implanter can be provided at determined intervals during long-term operation of implanting substrates to limit defect levels in implanted substrates over time. In the example of Figures 2A and 2B, high current dedicated implant results are shown for a given implant species. However, other high current implants of other species may also result in increased defect generation over time and may benefit from periodically implementing a pressure control routine for at least a portion of the beamline, such as a downstream portion of the beamline. In the dedicated implant example of Figure 2B, the pressure control threshold can be set to pause the implant operation at the point where the determined or calculated defect level approaches an acceptable limit. Thus, in the example of Figure 2B, when pressure control is implemented at intervals of about every 4000 wafers, the particle (defect) count can be expected to be 100 or less. Thus, if a value of 100 represents an acceptable defect limit, implementation of the pressure control routine at intervals of about 4000 wafer spacing can keep the defect level below the acceptable defect limit. Of course, with different defect limits (either greater than or less than 100), the size of the wafer gap implanted between successive runs of the pressure control routine can be increased or decreased.
[0031] According to additional embodiments of the present disclosure, the interval for implementing the pressure control regime can be set according to the total implant dose. For the data of FIG. 2B, each wafer is 1E15 / cm 2 The total implant dose for 4000 wafers is 1E19 / cm 2Note that by "particle count" it is meant to mean greater than 1E18 / cm. Without being limited to any particular theory, the increase in particle count may be caused at least in part by an increase in the amount of deposition from ion species collecting in the beamline, which is proportional to the total ion dose directed through the beamline over time. Thus, instead of setting a threshold for implementing a pressure control routine based on the number of wafers implanted, in some embodiments the threshold may be set according to the total implant dose. The total ion dose that corresponds to the creation of defect levels that reach the limit of acceptability may vary by implant species, but this range is in some non-limiting embodiments within the range of 1E18 / cm. 2 From 5E20 / cm 2 More specifically, between 1E19 / cm 2 From 1E20 / cm 2 Thus, according to certain embodiments, the threshold for implementing the pressure control routine may be between 1E18 / cm2 for a total ion dose generated for implanting multiple substrates. 2 From 1E20 / cm 2 Between 1E19 / cm and more specifically 1E19 / cm 2 From 1E20 / cm 2 It may be time to reach a point between
[0032] In further embodiments, the interval or instance for performing the pressure control procedure may be determined by a measurement of the thickness of the film accumulating in the beamline from the deposition of the species during implantation, such as in the electrostatic filter or the end station of the beamline, which may be performed by known means. In further embodiments, the instance for performing the pressure control routine may be triggered by a current measurement of an electrostatic electrode, such as a rod, in the electrostatic filter. Thus, the pressure control routine may be performed when the difference in the current collected at the electrodes reaches a threshold value. In one particular embodiment, the instance for performing the pressure control routine may be triggered by a capacitance measurement performed at the rod (electrode) of the electrostatic filter, which capacitance value is indicative of the film thickness accumulating at the electrode. Thus, the pressure control routine may be initiated when the capacitance reaches a threshold value.
[0033] 2C is a schematic diagram illustrating the principle of application of pressure control cycles to improve substrate processing efficiency, according to an embodiment of the present disclosure. In some examples, the pressure control cycles may be controlled, at least in part, by the controller 60 to direct various operations, as described in more detail below. FIG. 2C illustrates a pressure control cycle, T, which refers to the duration of the total period of time that the beamline is operating during preventive maintenance. processing Preventive maintenance refers to an entity named T PM , this preventive maintenance requires shutting down the beamline and opening up various parts of the beamline for maintenance procedures, such as cleaning and / or replacing eroded parts. A useful result is the entity T processing In the example of Figure 2C, cycling occurs between performing an ion implantation procedure on a first set of substrates during a first period of time (designated as P1) and performing a first pressure control routine during a second period of time (designated as P2).
[0034] In one example, at a minimum, a pressure control cycle may consist of performing an ion implantation procedure on a first set of substrates during a first time period (shown as P1), performing a first pressure control routine during a second time period (shown as P2), and performing ion implantation on a second set of substrates in a third time period, as represented by P3 in FIG. 4.
[0035] This cycling between performing an ion implantation procedure and performing a pressure control routine may continue to be repeated, with additional cycles represented in Figure 2C by a fourth time period P4 during which a second pressure control routine is performed, a fifth time period P5 during which an ion implantation procedure is performed on a third set of substrates, and a sixth time period P6 during which a third pressure control routine is performed, etc. According to embodiments of the present disclosure, the duration of a given ion implantation procedure may be determined when a threshold value is met or exceeded.
[0036] In the aforementioned examples, the threshold may represent the total number of substrates (wafers) being processed, the total ion implantation dose across several wafers, or the defect level. Thus, while in some examples when the threshold condition is met may be established by a predefined criterion, such as the number of substrates being processed, in some examples when the threshold is met may be determined more dynamically. For example, the total implantation ion dose may be correlated to the number of substrates being processed, especially if the same implantation recipe is repeated for each substrate, while the total implantation ion dose may be more accurately determined by measuring or recording the implantation of each substrate. Furthermore, the use of defect level as a measure of the threshold may be implemented dynamically in various manners, such as by a deposition sensor or particle counter disposed within the process chamber.
[0037] Returning now to FIG. 2C, the series of curves shown within a given injection period generally represent the increase in a parameter of interest, such as a measured deposition thickness in a process chamber, a particle count on a substrate, or other parameters. In some examples of threshold determination, the parameter of interest may increase linearly with time, such as the number of substrates being processed, while in other examples, the parameter of interest may increase non-linearly with time. Under certain processing conditions, the inventors have observed that the parameter associated with defect levels may increase non-linearly with time, and may actually increase more rapidly with increasing time, as suggested in FIG. 2C. Thus, in FIG. 2C, at the end of period P1, the parameter of interest increases more rapidly to reach a threshold, at which point the first pressure control routine is initiated.
[0038] As further suggested in FIG. 2C, in some instances, the duration of successive infusion periods (P3, P5, etc.) may be reduced. In other words, during each successive infusion period, the threshold condition may be reached more rapidly. At a given time, after at least one pressure control routine has been performed, the infusion device may be shut down and T PM A preventive maintenance period, denoted by P2, P4, P6, is planned. Nevertheless, implementation of a pressure control routine as described above may still be more efficient than today's procedures, where preventive maintenance may be planned based on a fixed number of substrates, or implantation time, or other criteria. Note that the duration of a pressure control routine (P2, P4, P6) may be on the order of just an hour or less, while the duration of a preventive maintenance including post-processing time may be on the order of several hours to 12 hours, and the duration of an implantation period may be on the order of many hours or tens of hours, such as 20-60 hours.
[0039] FIG. 2D is a schematic diagram illustrating operation of an ion implanter according to a reference maintenance cycle. In this example, the ion implanter is cycled through periods of implantation and preventive maintenance (PM), but without implementing the pressure control routine of the present embodiment. As such, for a given implantation procedure, the ion implanter may be operated through successive implantation periods (shown as T4, T5, and T6) in which the duration of the implantation periods remains the same. The implantation periods are interspersed with a series of preventive maintenance periods, as shown. The preventive maintenance periods may be scheduled based on predictions of when cleaning and / or replacement of eroded or contaminated parts may be required due to contamination buildup, as shown by the curves. A notable feature of the operation of an ion implanter according to FIG. 2D is that the relative duty cycle of the implantation ON time, the period during which implantation occurs, is smaller than the duty cycle of the implantation ON time for the embodiment of FIG. 2C. Moreover, the relative PM duty cycle of the PM time, the interval during which preventive maintenance occurs, is relatively higher in FIG. 2D than the PM duty cycle of FIG. 2C, meaning that relatively more time is spent performing maintenance in the reference case of FIG. 2D.
[0040] In other embodiments of the present disclosure, in addition to routine pressure control using natural gas, the use of a plasma source may be employed to generate plasma (e.g., at pressures of mTorr to atmospheric pressure) to generate film-modifying species in regions proximate to the substrate, including the electrostatic filter region, to further maintain particle levels at acceptable levels. This plasma source may generate plasma species, such as ions, metastable species, radical species, or molecular species, that may be used to bombard internal surfaces of the beamline in conjunction with application of pressure control routines to more efficiently remove materials that may act as particle sources.
[0041] 3 depicts an exemplary process flow, shown as process flow 300. At block 302, a given substrate "run" begins, where a series of substrates are implanted over a first interval in an end station (process chamber) of a beamline of an ion implantation system. In some non-limiting examples, the substrates may be wafers implanted using a dedicated recipe, such as boron, arsenic, carbon, or phosphorus implants. As such, defect (particle) levels may tend to increase with an increasing number of wafers during a substrate run.
[0042] At decision block 304, a periodic check may be performed by the ion implantation system as to whether a pressure control threshold has been reached. The pressure control threshold may correspond to a predefined number of wafers or may correspond to a total ion dose delivered over a first interval. The pressure control threshold may represent a value above which particle levels are predicted to reach or exceed acceptable limits. If not, flow proceeds to block 302 and implantation continues.
[0043] If the pressure control threshold is reached, flow proceeds to decision block 306 where a determination is made as to whether the substrate run is complete. If so, flow ends and the implant is terminated. If not, flow proceeds to block 308.
[0044] The downstream portion of the beamline is isolated in block 308. The downstream portion of the beamline may be isolated, for example, by engaging an isolation valve located immediately upstream of the collimator.
[0045] At least a downstream portion of the beamline is pressure controlled in block 310. A given pressure of a bleed gas, such as nitrogen, air, water vapor, reactive gas, or other gas, may be provided through one or more of the inlets provided in the beamline, such as in the downstream portion.
[0046] In block 312, the implant conditions are reset to resume the implant, such as a dedicated boron or phosphorous or carbon or arsenic ion implant. The reset may involve pumping out the bleed gas after a particular interval, such as one minute to one hour, and then providing the implant species to the ion source and resuming the implant.
[0047] In one variation of process flow 300, the operations of block 308 may be skipped and beamline pressure control may occur throughout the beamline in block 310.
[0048] This embodiment provides at least the following advantages: A first advantage is that by implementing a periodic pressure control routine, the level of contamination in the substrates being implanted can be maintained within an acceptable range for a larger volume of substrates. Another advantage is that the frequency of expensive and time-consuming shutdowns of the beamline and cleaning of beamline parts can be reduced because the pressure control routine maintains a lower level of defects without beamline shutdowns.
[0049] The present disclosure is not intended to be limited in scope by the specific embodiments described herein. Indeed, in addition to those described herein, various other embodiments and modifications to the present disclosure will be apparent to those skilled in the art from the foregoing description and the accompanying drawings. Thus, such other embodiments and modifications are intended to fall within the scope of the present disclosure. Furthermore, although the present disclosure is described herein in the context of specific implementations in specific environments for specific purposes, those skilled in the art will recognize that the usefulness is not limited thereto, and that the present disclosure may be beneficially implemented in any number of environments for any number of purposes. Thus, the claims set forth below should be construed in light of the full scope and spirit of the present disclosure as described herein.
Claims
1. 1. A method of operating a beam-line ion implanter, comprising the steps of: performing an ion implantation procedure on a first set of substrates for a first period of time in a process chamber of the beam-line ion implanter; When the threshold is exceeded, Pressure isolation of the downstream portion of the beamline; and introducing a predetermined gas into at least the downstream portion of the beamline for a second period of time to reach a predetermined pressure. performing a first pressure control routine during the second time period by performing the ion implantation procedure on a second set of substrates during a third period of time after completion of the first pressure control routine; Including, The threshold value is a measurement of a film thickness accumulating within the beam-line ion implanter during the first time period; a capacitance threshold measured at an electrode of an electrostatic filter of said beamline ion implanter; current measurements of the electrodes of the electrostatic filter; the duration of the first time period; or the total ion implant dose implanted during said first time period A method comprising:
2. The predetermined gases are nitrogen, Ar, Kr, Xe, H 2 , air, water vapor, reactive gases, CH 4 , C.H. x F y or a combination thereof.
3. The method of claim 1 , wherein performing the first pressure control routine comprises introducing the predetermined gas into the process chamber.
4. The threshold value is 1E19 / cm 2 to 5E20 / cm 2 The method of claim 1 , comprising a total ion implantation dose of
5. Implementing the first pressure control routine includes: The method of claim 1 , further comprising isolating pressure in the downstream portion of the beamline when the threshold is reached and before introducing the predetermined gas.
6. After the third period of time: implementing a second pressure control routine by introducing the predetermined gas into at least the downstream portion of the beamline over a fourth period of time to reach the predetermined pressure; 2. The method of claim 1, further comprising performing the ion implantation procedure on a third set of substrates during a fifth period of time after completion of the second pressure control routine.
7. 1. A method of operating a beam-line ion implanter, comprising the steps of: performing an ion implantation procedure on a first set of substrates for a first period of time in a process chamber of the beam-line ion implanter; implementing a first pressure control routine during a second time period by introducing a predetermined gas into at least a downstream portion of the beamline over the second time period to reach a predetermined pressure; performing the ion implantation procedure on a second set of substrates during a third period of time after completion of the first pressure control routine; performing a second pressure control routine after the third time period by introducing the predetermined gas into at least the downstream portion of the beamline for a fourth time period to reach the predetermined pressure; performing the ion implantation procedure on a third set of substrates during a fifth time period after completion of the second pressure control routine; Including, The method of claim 1, wherein the first pressure control routine is implemented when a first threshold is reached and the second pressure control routine is implemented after a second threshold is reached, the second threshold being less than the first threshold.
8. 8. The method of claim 7, wherein the first and second thresholds are based on a total duration of the ion implantation procedure, a total number of substrates implanted during the ion implantation procedure, a total ion dose performed during the ion implantation procedure, or a measured defect level within the beam line ion implanter during the ion implantation procedure.
9. The first threshold value and the second threshold value are a measurement of the thickness of a film accumulated in the beamline ion implanter; a capacitance threshold measured at an electrode of an electrostatic filter of said beamline ion implanter; or The value of the current measurement of the electrodes of the electrostatic filter The method of claim 7, comprising:
10. 10. The method of claim 1 , wherein the downstream portion of the beamline comprises an energy filter, the method further comprising using a plasma flood gun or a remote plasma source to generate a plasma proximate to the energy filter.
11. 11. The method of claim 10, wherein the plasma generates a plurality of metastable, radical, or molecular species that impinge on a wall of the process chamber, an inner surface of the energy filter, or a combination thereof to modify film deposits that accumulate on the wall of the process chamber, an inner surface of the energy filter, or a combination thereof.
12. 1. A beamline ion implanter comprising: an ion source for generating an ion beam according to an ion implantation procedure; a set of components for directing the ion beam along a beamline to a process chamber; a pressure control system comprising an isolation valve for isolating a downstream portion of the beamline from an upstream portion of the beamline, at least one inlet disposed downstream of the isolation valve for directing a predetermined gas into the downstream portion of the beamline, and a controller; Equipped with The controller is configured to direct the beam-line ion implanter to perform a pressure control cycle, the pressure control cycle comprising: performing the ion implantation procedure on a first plurality of substrates in the process chamber for a first period of time; When the threshold is exceeded, operating the isolation valve to isolate pressure in the downstream portion of the beamline; and introducing a predetermined gas into at least the downstream portion of the beamline for a second period of time to reach a predetermined pressure. performing a first pressure control routine during a second time period by: performing the ion implantation procedure on a second plurality of substrates during a third time period after completion of the first pressure control routine. Including, The threshold value is a measurement of a film thickness accumulating within the beam-line ion implanter during the first time period; a capacitance threshold measured at an electrode of an electrostatic filter of said beamline ion implanter; current measurements of the electrodes of the electrostatic filter; the duration of the first time period; or the total ion implant dose implanted during said first time period 1. A beamline ion implanter comprising:
13. 13. The beamline ion implanter of claim 12, wherein the at least one inlet is a process chamber inlet, a collimator inlet, or an energy filter inlet coupled to an energy filter.
14. The predetermined gases are nitrogen, air, Ar, Kr, Xe, H 2 , water vapor, reactive gas, CH 4 , C.H. x F y 13. The beamline ion implanter of claim 12, wherein the first and second electrodes are connected to each other.
15. A beamline ion implantation system comprising: an ion source for generating an ion beam according to an ion implantation procedure; a set of components for directing the ion beam along a beamline to a process chamber; a pressure control system comprising an isolation valve for isolating a downstream portion of the beamline from an upstream portion of the beamline, at least one inlet disposed downstream of the isolation valve for directing a predetermined gas into the downstream portion of the beamline, and a controller; Equipped with The controller is configured to direct the beam-line ion implanter to perform a pressure control cycle, the pressure control cycle comprising: performing the ion implantation procedure on a first plurality of substrates in the process chamber for a first period of time; implementing a first pressure control routine during a second time period by introducing a predetermined gas into at least the downstream portion of the beamline over a second time period to reach a predetermined pressure; performing the ion implantation procedure on a second plurality of substrates during a third period of time after completion of the first pressure control routine; performing a second pressure control routine after the third time period by introducing the predetermined gas into at least the downstream portion of the beamline for a fourth time period to reach the predetermined pressure; performing the ion implantation procedure on a third plurality of substrates during a fifth time period after completion of the second pressure control routine. Including, 1. A beam-line ion implanter, wherein the first pressure control routine is implemented when a first threshold is reached and the second pressure control routine is implemented after a second threshold is reached, the second threshold being less than the first threshold.
16. The beamline ion implanter of claim 15, wherein the first threshold and the second threshold are based on a total duration of the ion implantation procedure, a total number of substrates implanted during the ion implantation procedure, a total ion dose performed during the ion implantation procedure, or a measured defect level within the beamline ion implanter during the ion implantation procedure.
17. The first threshold value and the second threshold value are a measurement of the thickness of a film accumulated in the beamline ion implanter; a capacitance threshold measured at an electrode of an electrostatic filter of said beamline ion implanter; or The value of the current measurement of the electrodes of the electrostatic filter 16. The beam-line ion implanter of claim 15, comprising:
18. 16. The beamline ion implanter of claim 12 or 15, wherein the downstream portion of the beamline comprises an energy filter, and performing the first pressure control routine further comprises using a plasma flood gun or a remote plasma source to generate a plasma proximate to the process chamber, proximate to the energy filter, or proximate to both.
Citation Information
Patent Citations
Wafer orienting device
JP1983214261A
Ion implanting method, and device therefor
JP1995296764A
Ion doping device
JP1996077959A
Cleaning method for ion implanter
JP1999186185A
Ion implantation apparatus, ion generator and manufacture of semiconductor device
JP2000003881A
